Kasia Anderson / TruthdigOct 7, 2015
Some are bound to chalk this news up to the magical equalizing powers of capitalism’s famous "invisible hand," while others might point to the democratizing sting of actual journalism as the more potent force in this mix. Dig deeper ( 2 Min. Read )
Kasia Anderson / TruthdigOct 5, 2015
Another drug company has joined the likes of the recently exposed Turing Pharmaceuticals by jacking up prices of life-sustaining meds on extremely short notice. Remember this name: Valeant Pharmaceuticals International. Dig deeper ( 1 Min. Read )
BLANKSep 27, 2015
The drug company CEO who announced a 5,000 percent increase in the price of a lifesaving drug was forced to back down after Twitter users, the industry and others exploded in outrage. We have three words for these sometimes rude commenters: Good for you. Dig deeper ( 3 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Roisin Davis / TruthdigSep 23, 2015
Pharmaceuticals CEO Martin Shkreli is being called the most hated man in America for raising the price of the HIV drug Daraprim from $13.50 to $750 per pill. Now his earlier pricing decisions are being examined. It is being reported that one such decision led to a 2,000 percent price increase for a medication taken by children suffering from a rare kidney disease. Dig deeper ( 2 Min. Read )
Staff / TruthdigSep 23, 2015
In case you hadn't heard, last month, Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli got hold of the rights to parasite-zapping drug Daraprim, and then he had the bright idea to raise the price from $13.50 to $750 per pill. Now he has a big public relations problem and a self-created health care crisis on his hands. Dig deeper ( 1 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, please login or create a user profile.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, upgrade to supporter.